Abstract The coronavirus disease (COVID-19) has led to an rush to repurpose existing
drugs, although the underlying evidence base is of variable quality. Drug repurposing is a …

Despite the fact that coronavirus disease 2019 (COVID-19) treatment and management are
now considerably regulated, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Hypertension, diabetes mellitus, and coronary artery disease are common comorbidities and
dangerous factors for infection and serious COVID-19. Polymorphisms in genes associated …

Traditional Chinese medicines (TCMs) have been regularly prescribed to treat and prevent
diseases for thousands of years in the eastern part of the Asian continent. Thus, when the …

As the new year of 2020 approaches, an acute respiratory disease quietly caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus …

Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2, continues to be a global concern. Traditional Chinese medicines …

Abstract Coronavirus disease 2019 (COVID-19), first reported in Wuhan, China, has rapidly
spread worldwide. Traditional Chinese medicine (TCM) has been used to prevent and treat …

LianHuaQingWen (LHQW) improves clinical symptoms and alleviates the severity of COVID-
19, but the mechanism is unclear. This study aimed to investigate the potential molecular …

Abstract Background Lianhua Qingwen Capsules (LHQW) is a traditional Chinese medicine
prescription commonly used to treat viral influenza in China. There has been sufficient …

Supercritical anti-solvent fluidized bed (SAS-FB) technology can be applied to reduce
particle size, prevent particle aggregation, and improve the dissolution and bioavailability of …